Literature DB >> 12435085

A maximal effort trial in obese women carrying the beta2-adrenoceptor Gln27Glu polymorphism.

T Macho-Azcárate1, J Calabuig, A Martí, J A Martínez.   

Abstract

The aim of this study was to observe the relationship of the beta2-adrenoceptor (ADRB2) gene polymorphism Gln27Glu in a group of obese female subjects submitted to an acute physical activity test. Six Glu27/Glu27 obese women were compared with six Gln27/Gln27 obese women (coupled by age, BMI, waist circumference, percentage of fat mass and absence of smoking). These groups were selected after having genotyped 91 obese subjects (BMI>30 kg/m2, age 20-60). Polymerase chain reaction and restriction fragment length polymorphism (PCR-RFLP) were used to genotype the obese population. The physical activity challenge consisted of a Maximal effort trial (VO2 max) following the Bruce protocol on a walking treadmill. The frequency for the Glu allele was 0.42, which is similar to other Caucasian populations. In basal conditions, subjects with the Glu27/Glu27 genotype showed a higher value of plasma insulin, while circulating glucose levels were similar in both groups. Also, diastolic arterial pressure was higher in the Glu27/Glu27 obese women. After the VO2 max trial, the Glu27 group had a significantly higher respiratory exchange ratio than the Gln27 group suggesting a lower post- exercise fat oxidation. These results provide evidence about a possible impact of the Gln27Glu polymorphism in the ADRB2 gene concerning a better response to exercise in obese Gln27 female subjects, in which basal insulinemia may play a role.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12435085     DOI: 10.1007/bf03179845

Source DB:  PubMed          Journal:  J Physiol Biochem        ISSN: 1138-7548            Impact factor:   4.158


  17 in total

1.  The 27Glu polymorphism of the beta2-adrenergic receptor gene interacts with physical activity influencing obesity risk among female subjects.

Authors:  M S Corbalán; A Marti; L Forga; M A Martínez-González; J A Martínez
Journal:  Clin Genet       Date:  2002-04       Impact factor: 4.438

Review 2.  [Genetic studies of obesity in humans].

Authors:  T Macho Azcárate; A Martí del Moral; J A Martínez Hernández
Journal:  Med Clin (Barc)       Date:  2000-06-17       Impact factor: 1.725

Review 3.  Millennium fat-cell lipolysis reveals unsuspected novel tracks.

Authors:  D Langin; S Lucas; M Lafontan
Journal:  Horm Metab Res       Date:  2000 Nov-Dec       Impact factor: 2.936

4.  The effect of an increased free fatty acid concentration on thermogenesis and substrate oxidation in obese and lean men.

Authors:  S L Schiffelers; W H Saris; M A van Baak
Journal:  Int J Obes Relat Metab Disord       Date:  2001-01

5.  beta2-adrenoceptor gene polymorphisms and blood pressure variations in East Anglian Caucasians.

Authors:  H Jia; P Sharma; R Hopper; C Dickerson; D D Lloyd; M J Brown
Journal:  J Hypertens       Date:  2000-06       Impact factor: 4.844

Review 6.  Adrenoceptor genes in human obesity.

Authors:  P Arner; J Hoffstedt
Journal:  J Intern Med       Date:  1999-06       Impact factor: 8.989

7.  Blood pressure response during treadmill testing as a risk factor for new-onset hypertension. The Framingham heart study.

Authors:  J P Singh; M G Larson; T A Manolio; C J O'Donnell; M Lauer; J C Evans; D Levy
Journal:  Circulation       Date:  1999-04-13       Impact factor: 29.690

8.  Human beta-2 adrenoceptor gene polymorphisms are highly frequent in obesity and associate with altered adipocyte beta-2 adrenoceptor function.

Authors:  V Large; L Hellström; S Reynisdottir; F Lönnqvist; P Eriksson; L Lannfelt; P Arner
Journal:  J Clin Invest       Date:  1997-12-15       Impact factor: 14.808

9.  Positional genomic analysis identifies the beta(2)-adrenergic receptor gene as a susceptibility locus for human hypertension.

Authors:  M S Bray; J Krushkal; L Li; R Ferrell; S Kardia; C F Sing; S T Turner; E Boerwinkle
Journal:  Circulation       Date:  2000-06-27       Impact factor: 29.690

10.  Association of hypertension with beta2- and alpha2c10-adrenergic receptor genotype.

Authors:  L P Svetkey; P Z Timmons; O Emovon; N B Anderson; L Preis; Y T Chen
Journal:  Hypertension       Date:  1996-06       Impact factor: 10.190

View more
  1 in total

1.  CHO intake alters obesity risk associated with Pro12Ala polymorphism of PPARgamma gene.

Authors:  A Marti; M S Corbalán; M A Martínez-González; L Forga; J A Martínez
Journal:  J Physiol Biochem       Date:  2002-12       Impact factor: 4.158

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.